Bone quality assessed using quantitative ultrasound at the distal radius does not differ in antiretroviral therapy-naïve HIV-positive and HIV-negative Rwandan women

HIV Med. 2016 Nov;17(10):724-727. doi: 10.1111/hiv.12376.

Abstract

Objectives: The incidence of fractures appears to be increased in HIV-infected individuals.

Methods: We assessed bone quality using quantitative ultrasound (QUS) in HIV-infected and uninfected Rwandan women. A Sunlight Omnisense 7000 QUS was used to measure the speed of ultrasound (SOS) at the distal radius in 646 antiretroviral therapy (ART)-naïve HIV-infected women and 211 HIV-uninfected women. The Z-scores for SOS were based on data for women of the same age from the manufacturer's reference material.

Results: The mean CD4 cell count was 285 (± 166) cells/μL in the HIV-positive women. SOS Z-scores adjusted and unadjusted for body mass index did not differ between the groups. SOS did not differ by CD4 count (< 200 vs. ≥ 200 cells/μL: 4016 (± 117) vs. 4028 (± 107) m/s, respectively; p=0.19.

Conclusions: In HIV-positive ART-naïve Rwandan women with advanced HIV disease, bone quality at the distal radius was similar to that in HIV-negative controls.

Keywords: HIV; antiretroviral therapy; antiretroviral therapy-naïve; bone mineral density; women.

MeSH terms

  • Adult
  • Bone Density*
  • Bone Diseases / diagnostic imaging*
  • Female
  • HIV Infections / complications*
  • Humans
  • Middle Aged
  • Radius / diagnostic imaging*
  • Rwanda
  • Ultrasonography*